Rituximab: Sales - BioVenturist

BioVenturist

Share This

Rituximab

Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, and some autoimmune disorders. Rituximab was developed by IDEC...

Learn more about Rituximab »

Add More Topics

0 Sales topics matching:

Filter this Collection



and...

All topics Only topics with images

+

x Add new column Show in info bubble Show in info bubble Add new edge

Sales
- Amount
- » Currency
- Year
- » Area
- » Company Reporting
Other Columns Other Info
- » Also Typed With
- name
- Creation Date
- » creator

Edit Collection Schema

All topics in this collection are typed as Sales

View Type Schema

Use Data from this Collection

Choose a format:

Images and articles are not included in export files, which are limited to 1000 items. Complete data dumps are also available here.

Flag this Collection

Why do you want to flag this collection?

Label as possibly offensive